Practical therapeutic management of percutaneous atrial septal defect closure

Authors

Shuhei Tanaka
Teruhiko Imamura
Nikhil Narang, Advocate Aurora HealthFollow
Nobuyuki Fukuda
Hiroshi Ueno
Koichiro Kinugawa

Recommended Citation

Tanaka S, Imamura T, Narang N, Fukuda N, Ueno H, Kinugawa K. Practical Therapeutic Management of Percutaneous Atrial Septal Defect Closure. Intern Med. 2022;61(1):15-22. doi:10.2169/internalmedicine.5944-20

Affiliations

Advocate Christ Medical Center

Abstract

Atrial septal defects (ASDs) are one of the most common congenital heart disorders encountered by cardiologists. Percutaneous ASD closure for secundum ASD is commonly performed not only for children but also for adults, given its non-inferiority to surgical repair. The choice of closure technique should be based on assessing a patient's baseline comorbidities, including the presence of pulmonary hypertension, supraventricular tachycardias, and left ventricular diastolic dysfunction. Furthermore, anatomical features and defect types determined using echocardiography need to be considered when developing a management plan. Percutaneous closure is often the preferred method, given its comparable successful rate to surgical repair while also being far less invasive.

Document Type

Article

PubMed ID

33583888